Literature DB >> 30603272

A comparison study of patient ratings and safety of 32- and 34-gauge insulin pen needles.

Satoru Yamada1, Yoshifumi Yamada1, Yoko Tsukamoto1, Mitsuhisa Tabata1, Junichiro Irie1.   

Abstract

OBJECTIVE: Our aims were to compare diabetic patients' evaluations of straight 32- and tapered 34-gauge 4-mm needles for usability and preference as well as the frequency of injection adverse events during insulin self-injection and to analyze the relationship between patients' preferences and their background characteristics including thumb force measured by manual muscle testing.
METHODS: We enrolled 60 insulin-treated patients and measured their maximum thumb force. Patients were randomized into two groups (32- and 34-gauge) with reverse order of needle use: 1 week with one type of needle and the next week with the other. The usability of and preference for the needles were measured using the visual analog scale (VAS), and the frequency of injection adverse events was evaluated.
RESULTS: Mean maximum thumb strength was 83.5 ± 25.4 N, tended to decrease with age and was significantly lower in females than in males. The mean VAS scores regarding smooth insertion and pain during insulin delivery were significantly different, favoring the 34-gauge needle. However, the mean VAS scores regarding ease of pushing an injection button and overall preference showed no significant difference between the two needles. There was no significant difference in the frequency of injection adverse events including breaking needles.
CONCLUSION: Our patients had sufficient thumb force to push the injection button regardless of needle type. Although significant differences regarding smooth insertion or pain during insulin delivery were perceived, there was no difference in overall preference between the two needles, indicating the usability and safety of the two needles are not different in clinical use.

Entities:  

Keywords:  Diabetic patients; Insulin pen needle; Patient ratings; Thumb force

Year:  2015        PMID: 30603272      PMCID: PMC6224982          DOI: 10.1007/s13340-015-0242-y

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  20 in total

1.  The reliability of a linear analogue for evaluating pain.

Authors:  S I Revill; J O Robinson; M Rosen; M I Hogg
Journal:  Anaesthesia       Date:  1976-11       Impact factor: 6.955

2.  A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens.

Authors:  Hans Hemmingsen; Marcus Niemeyer; Marianne Rye Hansen; Ditlef Bucher; Niels Bjerrum Thomsen
Journal:  Diabetes Technol Ther       Date:  2011-08-24       Impact factor: 6.118

3.  A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus.

Authors:  Sherwyn Schwartz; David Hassman; John Shelmet; Richard Sievers; Richard Weinstein; John Liang; William Lyness
Journal:  Clin Ther       Date:  2004-10       Impact factor: 3.393

4.  Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes.

Authors:  Laurence J Hirsch; Michael A Gibney; John Albanese; Shankang Qu; Kenneth Kassler-Taub; Leslie J Klaff; Timothy S Bailey
Journal:  Curr Med Res Opin       Date:  2010-06       Impact factor: 2.580

5.  Force requirements and insulin delivery profiles of four injection devices.

Authors:  Kenichi Toraishi; Yoichi Yuizono; Noriko Nakamura; Shino Kato; Tsuyoshi Aoki; Kenji Ashida; Yasuhiro Sako
Journal:  Diabetes Technol Ther       Date:  2005-08       Impact factor: 6.118

Review 6.  New injection recommendations for patients with diabetes.

Authors:  A Frid; L Hirsch; R Gaspar; D Hicks; G Kreugel; J Liersch; C Letondeur; J P Sauvanet; N Tubiana-Rufi; K Strauss
Journal:  Diabetes Metab       Date:  2010-09       Impact factor: 6.041

7.  Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.

Authors:  Michael A Gibney; Christina H Arce; Karen J Byron; Laurence J Hirsch
Journal:  Curr Med Res Opin       Date:  2010-06       Impact factor: 2.580

8.  Comparison of patient's preference, pain perception, and usability between Micro Fine Plus 31-gauge needle and Microtapered NanoPass 33-gauge needle for insulin therapy.

Authors:  Masashi Miyakoshi; Kyuzi Kamoi; Midori Iwanaga; Ayako Hoshiyama; Ayako Yamada
Journal:  J Diabetes Sci Technol       Date:  2007-09

9.  Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles.

Authors:  Midori Iwanaga; Kyuzi Kamoi
Journal:  Diabetes Technol Ther       Date:  2009-02       Impact factor: 6.118

10.  Preference and resource utilization in elderly patients: InnoLet versus vial/syringe.

Authors:  John Shelmet; Sherwyn Schwartz; John Cappleman; Gregory Peterson; Soren Skovlund; Lene Lytzen; Lars Nicklasson; John Liang; William Lyness
Journal:  Diabetes Res Clin Pract       Date:  2004-01       Impact factor: 5.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.